Date: July 29, 2026

Financial Results (Standalone & Consolidated)

The unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27) are as follows:

Profit & Loss Statement (₹ in lakhs):

  • Insurance Revenue: ₹491.72 crore
  • Insurance Service Expenses: ₹447.14 crore
  • Net expenses/income from reinsurance contracts: ₹2.07 crore
  • Insurance Service Result: ₹42.51 crore
  • Investment Income: ₹64.36 crore
  • Net Finance Result: ₹60.49 crore
  • Other Revenue/expenses (net): (₹8.83) crore
  • Profit before Exceptional Items: ₹54.97 crore
  • Exceptional Items: ₹0.70 crore
  • Current tax: ₹13.02 crore
  • Deferred tax: ₹6.18 crore
  • Profit from continuing operations: ₹54.97 crore
  • Profit from discontinued operations: ₹0.00 crore
  • Profit for the period: ₹54.97 crore
  • Other Comprehensive Income: ₹0.00 crore
  • Total Comprehensive Income: ₹54.97 crore

Comparative Figures (₹ in lakhs):

  • Q1 FY27 Profit: ₹54.97 crore (unaudited)
  • Q4 FY26 Profit/(Loss): (₹5.54) crore (unaudited)
  • Q1 FY26 Profit: ₹43.82 crore (unaudited)
  • Year to date ended Mar 31, 2026: ₹91.10 crore (unaudited)

Balance Sheet Highlights (as of June 30, 2026, ₹ in lakhs):

  • Total Assets: ₹23,78,004
  • Total Liabilities: ₹13,63,581
  • Investment Contract Liabilities: ₹10,92,199
  • Insurance Contract liabilities: ₹2,71,382
  • Reinsurance Contract liabilities: ₹58,858
  • Total Equity: ₹10,14,423

Earnings Per Share (for continuing operations):

  • Basic: ₹9.34
  • Diluted: ₹9.33

Analytical Ratios:

  • Insurance Service Margin: 9.07%
  • Insurance Finance Margin: 0.79%
  • Net Insurance Margin: 20.95%
  • Claims Ratio: 67.48%
  • Expense Ratio: 23.45%
  • Combined Operating Ratio (CoR): 90.93%
  • Solvency Ratio: 2.09
  • Return on Equity (RoE): 5.57%
  • Gross Written Premium (GWP): ₹4,28,713
  • Expected Credit Loss Ratio: 0.06%

Segment-wise Performance (₹ in lakhs)

Total Segment Income: ₹5,56,840

Health Segment:

  • Insurance Revenue: ₹4,86,790
  • Income from Investments: ₹63,881
  • Other Income: ₹745
  • Insurance Service Result: ₹42,510 (after expenses of ₹4,42,422)
  • Segment Profit: ₹54,557

Personal Accident Segment:

  • Insurance Revenue: ₹4,769
  • Income from Investments: ₹455
  • Other Income: ₹5
  • Segment Profit: ₹388

Travel Segment:

  • Insurance Revenue: ₹161
  • Income from Investments: ₹33
  • Other Income: ₹1
  • Segment Profit: ₹28

KMP / Board / Auditor Changes

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

Board Meeting Outcomes

The Board of Directors approved the financial results at their meeting held on July 29, 2026.

Auditor’s Report

The joint statutory auditors, MSKA & Associates LLP and T R Chadha & Co LLP, conducted a limited review of the financial results. Their report states: "Based on our review... nothing has come to our attention that causes us to believe that the accompanying Statement... contains any material misstatement."

Disinvestment / Strategic Actions

Not Specified

Other Operational / Legal / Strategic Disclosures

Employee Stock Option (ESOPs):

  • ESOP 2024: During the quarter, the company granted 10,90,409 ESOP options.
  • Total compensation cost for the quarter: ₹1,249 lakhs.

Changes in Share Capital:

  • Allotment - ESOP 2019: The company allotted 1,73,407 equity shares (face value ₹10 each) pursuant to exercise of stock options.

Ind AS Adoption:

  • The company adopted Indian Accounting Standards (Ind AS) effective FY2026-27 with transition date of April 1, 2025.
  • Key reconciliation adjustments between previous GAAP and Ind AS:
  • Ind AS 117 - Insurance Contract: ₹(5,100) lakh impact on Q1 FY26 net profit
  • Ind AS 109 - Fair Valuation of Financial Instruments: ₹29,207 lakh impact on Q1 FY26 net profit
  • Deferred tax impact: ₹(6,041) lakh impact on Q1 FY26 net profit

Status of Shareholders Complaints:

  • No investor complaints pending at the beginning of the quarter
  • No complaints received during the quarter
  • No complaints disposed of during the quarter
  • No complaints unresolved at the end of the quarter

Utilization of Issue Proceeds:

  • There are no issue proceeds pending for utilization
  • No deviation or variation in use of issue proceeds for the quarter

Notes:

  • The Appointed Actuary has certified the actuarial estimates for IBNR reserves.
  • Due to industry seasonality, quarterly results are not indicative of full-year performance.
  • Figures for previous periods have been re-grouped to conform to current presentation and regulatory requirements.